We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 47

The National Roundtable on the Environment and Economy report - Paying the Price: The Economic Impacts of Climate Change for Canada
  • Gowling WLG
  • Canada
  • October 18 2011

The National Roundtable on the Environment and Economy has released its latest report, Paying the Price: The Economic Impacts of Climate Change for Canada.


Bristol-Myers Squibb Canada Co. and Merck Sharp & Dohme Corp. v Mylan Pharmaceuticals, 2011 FC 919, July 25, 2011 - efavirenz
  • Gowling WLG
  • Canada
  • August 22 2011

As a part of a Patented Medicines (Notice of Compliance) Regulations proceeding, the applicants had filed a motion for the production of certain further documents by the respondent, namely documents that would go to what crystalline forms were used in the making of the generic product, including under s. 6(7) of the Regulations.


Release of the Alberta Environmental Monitoring Panel Report and the integrated oil sands environment monitoring plan
  • Gowling WLG
  • Canada
  • August 5 2011

On July 5, 2011, the Alberta Government released the Environmental Monitoring Panel Report to the public.


Timely accident investigations can help reduce costs now and legal risk in the future
  • Gowling WLG
  • Canada
  • May 10 2011

After a workplace incident occurs, it is important to conduct a thorough accident investigation as soon as possible.


Apotex v. BMS (2011 FCA 34), nefazodone, A-94-11 (T-2078-00), March 2, 2011
  • Gowling WLG
  • Canada
  • March 15 2011

The Federal Court of Appeal summarily denied Apotex' motion to expedite its appeal of a decision of the Federal Court (February 21, 2011) denying Apotex leave to file sur-reply expert reports on infringement.


GSK v. Pharmascience (2011 FC 239), rosiglitazone, T-1687-09, March 1, 2011
  • Gowling WLG
  • Canada
  • March 15 2011

The Court granted an application for an Order of prohibition brought under the Patented Medicines (Notice of Compliance) Regulations regarding rosiglitazone.


Hospira v Eli Lilly, appeal of order for further and better production of documents, gemcitabine, October 26, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

Eli Lilly alleged that gemcitabine made in China and imported into Canada by Hospira infringes Eli Lilly's patent for an intermediate process step in the manufacture of gemcitabine.


Merck-Frosst-Schering Pharma GP v. Canada (Health) (2010 FC 933)
  • Gowling WLG
  • Canada
  • October 27 2010

Merck-Frosst (“Merck”) applied for an order prohibiting the Minister of Health from issuing a Notice of Compliance to Teva for its generic version of Ezetimibe.


Apotex v Sanofi, case management directions on the late disclosure of documents or information
  • Gowling WLG
  • Canada
  • May 21 2010

Prior to a case management conference within a streamlined case, the Prothonotary ordered the parties to make submissions at the conference on the question of whether a date should be set after which the parties required either consent of the other party or leave of the Court to serve a supplementary affidavit of documents or a corrected or completed information in answer to a discovery question.


New guidelines for “specialized knowledge” intra-company transfers to Canada
  • Gowling WLG
  • Canada
  • April 23 2010

Both NAFTA and IRPA have a work permit category which assists in the transfer of foreign workers to Canada from a foreign related entity.